Cultivating Cannabinoid Safety Data In US: Principles, Projects And Problems
Executive Summary
FDA offers guiding principles for research on cannabinoids’ use in food, supplements and lotions and other personal care products. It also identifies challenges to studies that generate robust data about use of the ingredients.
You may also be interested in...
Wisconsin Doctor’s CBD Nasal Sprays, Topical Offered OTC Diagnosed As Unapproved Drugs
Nasadol CBD Nasal Sprays not only are violative for claims unallowed for CBD, but for containing CBD. FDA also warns online pharmacy about fraudulent OTC COVID-19 cure kit.
Bausch Health Has Full Plate While Trimming Debt, Setting Table For Bausch + Lomb Separation
Bausch Health says it’s continuing a recovery from the disaster previous management left, when the firm operated as Valeant Pharmaceuticals, even though it reported a $595m net loss for Q2. “We've been trying to solve this debt issue for the company,” says CEO Joseph Papa.
Church & Dwight Cuts Outlook Due To Rising Costs, Adds Suppliers To Strengthen ‘Weak Links’
“We expect higher input costs and transportation costs to remain elevated for the rest of the year,” says CEO Matthew Farrell. Firms lowers full-year outlook for net sales growth from previous range of 5% to 6% to around 5%.